Hematopoietic-Specific Heterozygous Loss of Dnmt3a Exacerbates Colitis-Associated Colon Cancer

Scientists hypothesized that bone marrow–derived cells with heterozygous loss-of-function mutations of DNMT3A, the most common genetic alteration in clonal hematopoiesis, contributed to the pathogenesis of colon cancer.